Bioparox - a drug for the treatment of diseases of the lungs and bronchi.
Thanks to the active ingredients of the drug - fusafungine, Antibiotics polypeptide, the use of anti-inflammatory Bioparox, fungistatic, bacteriostatic action.
By the action of Bioparox susceptible staphylococci, infectious agents mucous membranes, acne, food poisoning, some coccobacillus, Listeria, Bacillus subtilis.
Bioparox discharged in aerosol form for topical treatment.
Effective use Bioparox in local treatment of acute inflammatory diseases of the upper respiratory tract, ENT organs, including infectious origin.
In particular, the diseases caused by microorganisms sensitive to fusafungine: sinusitis, nasopharyngitis, rhinitis, pharyngitis, laryngitis, tonsillitis, bronchitis, tracheitis.
It is also possible to use Bioparox for the prevention and treatment of diseases arising after the tonsillectomy.
Instructions for use Bioparox
According to the instructions Bioparox used for inhalation through the nose or mouth.
In inflammatory diseases of the nasal mucosa - rhinitis, nasopharyngitis, sinusitis, the drug is administered through the nasal passages, clearing before it nose of mucus. The drug is administered, holding free nostril, closing the mouth and nose, took a deep breath.
In diseases of the upper respiratory tract, mucous membrane of the throat (tracheitis, bronchitis, tonsillitis, laryngitis, pharyngitis) and after tonsillectomy Bioparox introduced through the mouth, deep breath. For a better irrigation of the bronchi and trachea patient should hold their breath a little after the introduction Bioparox.
Nozzles for inhalation that are included with the vial should be disinfected every day, wiping with ethyl alcohol 90%.
According to the instructions Bioparox adults and children, which was 12 l. Appoint four doses to be administered by mouth or by 2 doses 4 p / day in each nostril.
2 children, 5 -12l. 2-4 doses administered Bioparox for administration orally or by one or two doses to be administered through the nose (4 / day in each nostril).
The average duration of treatment is not more than a week (otherwise may develop superinfection).
Application Bioparox rarely causes side effects, but documented cases where patients taking the drug arose dry mucous membranes, burning sensation, bronchospasm, asthma, sneezing, coughing, laryngospasm, edema, respiratory failure, nausea, unpleasant taste in your mouth, tearing, changing taste, eye redness, itching, skin rash, hives, anaphylactic shock (isolated cases).
Do not appoint Bioparox with individual patient's sensitivity to the constituents means children under the age of 2, 5 liters.
Be wary appoint Bioparox those who have observed the tendency to allergic reactions.
No clinical data on the possibility of using Bioparox during pregnancy is not recommended its use without consulting with a doctor. Appointment Bioparox during pregnancy is possible if it is established that the risk to the child is less than the benefit to the mother.
We do not recommend the use of Bioparox and lactation.